Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies

Condition:   Head and Neck Cancer
Intervention:   Drug: Apatinib
Sponsors:   China International Medical Foundation;   Chinese Society of Clinical Oncology
Not yet recruiting

https://ift.tt/2LKrFke